Literature DB >> 21562478

Imaging: MRSI can potentially differentiate between aggressive and indolent prostate cancer.

Nick Warde.   

Abstract

Entities:  

Year:  2011        PMID： 21562478     DOI： 10.1038/nrurol.2011.59

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.

Authors:  Thiele Kobus; Thomas Hambrock; Christina A Hulsbergen-van de Kaa; Alan J Wright; Jelle O Barentsz; Arend Heerschap; Tom W J Scheenen
Journal:  Eur Urol       Date:  2011-03-17       Impact factor: 20.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.